Insiders Spexis AG

Equities

Delayed Swiss Exchange Other stock markets 05:05:49 2024-05-27 am EDT			5-day change	1st Jan Change
0.0706 ^CHF	+19.66%		+2.32%	+72.20%

May. 01	SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication	MT
Apr. 17	Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis	MT

Ascom Hires New CFO	Mar. 21	MT
Spexis CFO to Step Down, Interim CFO Named	Nov. 01	MT
Muriel Fleming Joins Spexis AG as Executive Committee, Effective December 1, 2023	Nov. 01	CI
Spexis AG Announces Appointment of Gonçalo Bernardes as Acting Head of Chemical Biology	23-09-28	CI
Destiny Pharma picks interim CEO as Clark makes quick exit	23-05-25	AN
Polyphor Finalizes Merger With EnBiotix, to Change Name to Spexis	21-12-30	MT
Polyphor, EnBiotix Shareholders Green-Light Merger, Name Change	21-10-29	MT
Polyphor AG Announces Executive Changes	21-10-29	CI
Polyphor AG Announces Executive Changes	21-09-27	CI
Jean-Pierre Obrecht Announces Not to Stand for Re-Election to Its Board of Directors of Polyphor AG	20-05-05	CI
Polyphor AG Announces Executive Changes	20-01-23	CI
Polyphor Ag Announces Management Changes	19-11-20	CI
Polyphor AG Announces Appointment of Frank Weber as Chief Medical and Development Officer, Effective September 1, 2019	19-07-19	CI
Polyphor AG Appoints Gökhan Batur as Chief Commercial Officer, Effective from June 3, 2019	19-04-09	CI
Debra Barker to Leave from Polyphor as Chief Medical and Development Officer	18-10-24	CI
Polyphor Names Kalina Scott as Chief Financial Officer, Effective from June 1St, 2017	17-05-23	CI
Polyphor Announces Executive Changes	17-03-20	CI
Polyphor Appoints Debra Barker as Chief Medical and Development Officer, Effective May 01, 2017	17-03-06	CI
Polyphor AG Appoints Giacomo Di Nepi as CEO, Effective November 1, 2016	16-10-18	CI
Polyphor Ltd. Announces Management Changes	15-03-16	CI

No results for this search